Product information

Current status:

Cancelled Pre Market

Current status date:

2021-04-09

Original market date: ^{See footnote 1}

Product name:

FLURAZEPAM 30MG CAPSULE

DIN:

02232657 Electronic product monograph is not available

Company:

LABORATOIRES CONFAB INC
4355 Boul. Sir Wilfrid Laurier
St-Hubert
Quebec
Canada J3Y 3X3

Class:

Human

Dosage form(s):

Capsule

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Targeted (CDSA IV)

American Hospital Formulary Service (AHFS): ^{See footnote 3}

28:24.08 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

N05CD01 FLURAZEPAM

Active ingredient group (AIG) number:^{See footnote5}

0108704001